Navigation Links
Sugars Could Contain Key Cancer Inhibiting Compounds

An Association for International Cancer Research team has come out with the startling finding that a natural compound found in glucose blocks the development of tumors in mice. This discovery could be vital in fighting cancer and // related illnesses.

The sugar molecules work by blocking the hormones that are essential for the growth of blood vessels in the tumor. In effect they strangle the tumor by blocking blood and nutrient supply to it. Cancer experts are now looking at sugar to halt the growth of tumors before they get out of hand and metastasize causing serious harm. The Clinical Cancer Research journal reports that this technique uses a complex natural sugar called heparin. "If someone has cancer, it has often spread so what you may find is that this treatment could be used once the initial tumor has been removed. It could be used to stop the cancer cells developing when they have spread. But we will have to see how it develops in future trials," said Dr Mark Matfield, scientific consultant of Association for International Cancer Research.

This sugar treatment is effective only in reducing tumor size when it is detected early, but researchers are hopeful of finding ways to integrate this treatment into the normal cancer therapy. Lead researcher Professor Gordon Jayson, of the Manchester's Christie's Hospital was confident that they could begin clinical trials in two years' time. Dr Kat Arney, science information officer at Cancer Research UK said that the research had exciting potential and could point the way to future cancer treatments, "Because adults don't normally need to grow new blood vessels, this discovery could lead to a highly specific and effective treatment for many types of cancer. However, this research is still at an early stage and it will be essential to develop these sugars further and test their actions in patients," she commented.
'"/>




Page: 1

Related medicine news :

1. Sugars in Liver Found to Clear Fats from the Bloodstream
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Nasal Spray Could Take Drugs Directly to Brain
5. Oxygen Usage During Exercise Could Indicate Heart Problems
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. Anger Could Be Linked To Weight Gain
8. A Seizure Late In Life Could be A Stroke Warning
9. New Findings Could Reduce The Extent Of Spinal Cord Injuries
10. Could There Be A Link Between Famine and Breast Cancer ?
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... Park Systems , a leader in Atomic ... SEMICONWest attendees and Park customers on July 11, 2017 from 12-2pm at the ... Chairman & CEO of Park Systems, and Prof. Krishna Saraswat , Rickey/Nielsen Professor ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner Financial, ... regions access to insurance assistance and financial planning services, is announcing the commencement ... families in the region facing financial crisis. , Matthew 25: Ministries (M25M) is ...
(Date:6/27/2017)... ... 2017 , ... Excel Medical, the leader in Next-Generation Medical ... Executive Vice President, Sales and Marketing. Finnegan is a widely known industry leader ... leadership. He has received industry recognition for innovations and new approaches to sales ...
(Date:6/27/2017)... , ... June 27, 2017 , ... Harbour , ... token assets on the Ethereum blockchain, has released their technical specifications . , ... there has been little systematic approach for determining which offerings will garner the greatest ...
(Date:6/27/2017)... ... June 27, 2017 , ... ... Association’s SUNucate efforts, Louisiana became the sixth state to pass legislation which ... Governor John Bel Edwards’ signature, Louisiana joins the states of Alabama, Arizona, Florida, ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... Ind. , June 13, 2017 Zimmer Biomet ... musculoskeletal healthcare, today announced that the U.S. Food and Drug ... dated June 3, 2015 relating to its Zhejiang, ... "The successful clearance of the ... manufacturing facility is a measure of the progress ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company ... from three Phase 3 studies of galcanezumab, an investigational ... including late-breaking data on several key secondary endpoints for ... results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will ... annual scientific meeting in Boston . ...
(Date:6/9/2017)... 9, 2017 AirXpanders, Inc. (ASX: AXP) (AirXpanders ... design, manufacture, sale and distribution of the AeroForm® Tissue ... of its commercial roll-out in the United ... than one hundred (100) medical institutions and health systems, ... a needle-free alternative for women who choose reconstructive surgery ...
Breaking Medicine Technology: